Li Zhao

机构：United States Geological Survey, The University of Texas MD Anderson Cancer Center, University of Shanghai for Science and Technology, Tianjin Medical University Cancer Institute and Hospital, Huaiyin Institute of Technology · ORCID：0000-0002-1378-7434

发表论文 128 篇 · 总被引 5285 次 · h-index 36

代表论文

• Jinlida for Diabetes Prevention in Impaired Glucose Tolerance and Multiple Metabolic Abnormalities (2024 · JAMA Internal Medicine · 被引 33)
• SLC25A21 downregulation promotes KRAS-mutant colorectal cancer progression by increasing glutamine anaplerosis (2023 · JCI Insight · 被引 18)
• USP9X integrates TGF-β and hypoxia signalings to promote ovarian cancer chemoresistance via HIF-2α-maintained stemness (2025 · Cell Death and Disease · 被引 15)
• Metabolic syndrome, genetic susceptibility, and risk of chronic obstructive pulmonary disease: The UK Biobank Study (2023 · Diabetes Obesity and Metabolism · 被引 14)
• Targeting miR‐31 represses tumourigenesis and dedifferentiation of BRAF V600E ‐associated thyroid carcinoma (2024 · Clinical and Translational Medicine · 被引 13)
• miR-22 promotes immunosuppression via activating JAK/STAT3 signaling in cutaneous squamous cell carcinoma (2023 · Carcinogenesis · 被引 11)